To what extent do educational interventions impact medical trainees' attitudes and behaviors regarding industry-trainee and industry-physician relationships?

Pediatrics

Volumn 120, Issue 6, 2007, Pages

  Carroll, Aaron E ^a,b,c   Vreeman, Rachel C ^a   Buddenbaum, Jennifer ^a   Inui, Thomas S ^a,b  

^a INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b REGENSTRIEF INSTITUTE   (United States)

^c HITS Building ^*  (United States)

Author keywords

Gifts; Medical education; Pharmaceutical industry; Residents; Students

Indexed keywords

ACCREDITATION; ARTICLE; DRUG INDUSTRY; HUMAN; MEDICAL EDUCATION; MEDLINE; PHYSICIAN ATTITUDE; POLICY; PRIORITY JOURNAL;

DRUG INDUSTRY; EDUCATION, MEDICAL; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; INTERNSHIP AND RESIDENCY; INTERPROFESSIONAL RELATIONS; PHYSICIANS; STUDENTS, PHARMACY;

EID: 36849015852     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2007-0363     Document Type: Article

References (38)

1. Studdert DM, Mello MM, Brennan TA. Financial conflicts of interest in physicians' relationships with the pharmaceutical industry: self-regulation in the shadow of federal prosecution. N Engl J Med. 2004;351:1891-1900
2. Brennan TA, Rothman DJ, Blank L, et al. Health industry practices that create conflicts of interest: a policy proposal for academic medical centers. JAMA. 2006;295:429-433
3. Blumenthal D. Doctors and drug companies. N Engl J Med. 2004;351:1885-1890
4. Chren MM. Interactions between physicians and drug company representatives. Am J Med. 1999;107:182-183
5. Brett AS, Burr W, Moloo J. Are gifts from pharmaceutical companies ethically problematic? A survey of physicians. Arch Intern Med. 2003;163:2213-2218
6. Wazana A. Physicians and the pharmaceutical industry: is a gift ever just a gift? JAMA. 2000;283:373-380
7. Lexchin J. Interactions between physicians and the pharmaceutical industry: what does the literature say? CMAJ. 1993;149:1401-1407
8. Croasdale M. Some medical schools say no to drug reps' free lunch. Am Med News. Available at: www.ama-assn.org/amednews/2006/10/09/prl21009.htm. Accessed September 24, 2007
9. Coleman D, Kazdin A, Miller L, Morrow J, Udelsman R. Guidelines for interactions between clinical faculty and the pharmaceutical industry: one medical school's approach. Acad Med. 2006;81:154-160
10. Sierles FS, Brodkey AC, Cleary LM, et al. Medical students' exposure to and attitudes about drug company interactions: a national survey. JAMA. 2005;294:1034-1042
11. Zipkin DA, Steinman MA. Interactions between pharmaceutical representatives and doctors in training: a thematic review. J Gen Intern Med. 2005;20:777-786
12. Keim SM, Sanders AB, Witzke DB, Dyne P, Fulginiti JW. Beliefs and practices of emergency medicine faculty and residents regarding professional interactions with the biomedical industry. Ann Emerg Med. 1993;22:1576-1581
13. McCormick BB, Tomlinson G, Brill-Edwards P, Detsky AS. Effect of restricting contact between pharmaceutical company representatives and internal medicine residents on posttraining attitudes and behavior. JAMA. 2001;286:1994-1999
14. Lichstein PR, Turner RC, O'Brien K. Impact of pharmaceutical company representatives on internal medicine residency programs: a survey of residency program directors. Arch Intern Med. 1992;152:1009-1013
15. Shear N, Black F, Lexchin J. Examining the physician-detailer interaction. Can J Clin Pharmacol. 1996;3:175-179
16. Kelcher S, Brownoff R, Meadows LM. Structured approach to pharmaceutical representatives: family medicine residency program. Can Fam Physician. 1998;44:1053-1056
17. Watkins RS, Kimberly J Jr. What residents don't know about physician-pharmaceutical industry interactions. Acad Med. 2004;79:432-437
18. Brotzman GL, Mark DH. The effect on resident attitudes of regulatory policies regarding pharmaceutical representative activities. J Gen Intern Med. 1993;8:130-134
19. Vinson DC, McCandless B, Hosokawa MC. Medical students' attitudes toward pharmaceutical marketing: possibilities for change. Fam Med. 1993;25:31-33
20. Shaughnessy AF, Slawson DC, Bennett JH. Teaching information mastery: evaluating information provided by pharmaceutical representatives. Fam Med. 1995;27:581-585
21. Anastasio GD, Little JM Jr. Pharmaceutical marketing: implications for medical residency training. Pharmacotherapy. 1996;16:103-107
22. Hopper JA, Speece MW, Musial JL. Effects of an educational intervention on residents' knowledge and attitudes toward interactions with pharmaceutical representatives. J Gen Intern Med. 1997;12:639-642
23. Wilkes MS, Hoffman JR. An innovative approach to educating medical students about pharmaceutical promotion. Acad Med. 2001;76:1271-1277
24. Agrawal S, Saluja I, Kaczorowski J. A prospective before-and-after trial of an educational intervention about pharmaceutical marketing. Acad Med. 2004;79:1046-1050
25. Randall ML, Rosenbaum JR, Rohrbaugh RM, Rosenheck RA. Attitudes and behaviors of psychiatry residents toward pharmaceutical representatives before and after an educational intervention. Acad Psychiatry. 2005;29:33-39
26. Stanley AG, Jackson D, Barnett DB. The teaching of drug development to medical students: collaboration between the pharmaceutical industry and medical school. Br J Clin Pharmacol. 2005;59:464-474
27. Wofford JL, Ohl CA. Teaching appropriate interactions with pharmaceutical company representatives: the impact of an innovative workshop on student attitudes. BMC Med Educ. 2005;5:5
28. Schneider JA, Arora V, Kasza K, Van Harrison R, Humphrey H. Residents' perceptions over time of pharmaceutical industry interactions and gifts and the effect of an educational intervention. Acad Med. 2006;81:595-602
29. Spingarn RW, Berlin JA, Strom BL. When pharmaceutical manufacturers' employees present grand rounds, what do residents remember? Acad Med. 1996;71:86-88
30. Chew LD, O'Young TS, Hazlet TK, Bradley KA, Maynard C, Lessler DS. A physician survey of the effect of drug sample availability on physicians' behavior. J Gen Intern Med. 2000;15:478-483
31. Schwartz TL, Kuhles DJ 2nd, Wade M, Masand PS. Newly admitted psychiatric patient prescriptions and pharmaceutical sales visits. Ann Clin Psychiatry. 2001;13:159-162
32. Boltri JM, Gordon ER, Vogel RL. Effect of antihypertensive samples on physician prescribing patterns. Fam Med. 2002;34:729-731
33. Adair RF, Holmgren LR. Do drug samples influence resident prescribing behavior? A randomized trial. Am J Med. 2005;118:881-884
34. Ziegler MG, Lew P, Singer BC. The accuracy of drug information from pharmaceutical sales representatives. JAMA. 1995;273:1296-1298
35. Sandberg WS, Carlos R, Sandberg EH, Roizen MF. The effect of educational gifts from pharmaceutical firms on medical students' recall of company names or products. Acad Med. 1997;72:916-918
36. Mintzes B. Educational Initiatives for Medical and Pharmacy Students About Drug Promotion: An International Cross-Sectional Survey. Geneva, Switzerland: World Health Organization; 2005. Available at: www.haiweb.org/ 26012006/MRhaipromosurveyFINAL06.pdf. Accessed September 5, 2007
37. Wadland WC, Farquhar L, Priester F, Oberst K, Weismantel DP. Increasing generic prescribing: a resident educational intervention. Fam Med. 2005;37:259-264
38. Association of American Medical Colleges. New AAMC task force to examine health industry influence on medical education [press release]. Available at: www.aamc.org/newsroom/pressrel/2006/060221.htm. Accessed February 28, 2006